483 Allergan, PLC. Apr 2019

483 Allergan, PLC. Apr 2019

Michael Serrano FDA$119.00 - Available Now

FDA investigators audited the Allergan, PLC. - Madison, NJ, United States facility and issued inspectional observations (via FDA 483) on 11 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Apr 2019
  • Location: Madison, United States
  • FEI: 3008162988
Add To Cart